Renal amyloidosis surgery

	Renal amyloidosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Renal amyloidosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiography or Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Template:Renal amyloidosis On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Renal amyloidosis surgery All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Renal amyloidosis surgery
CDC on Renal amyloidosis surgery
Renal amyloidosis surgery in the news
Blogs on Renal amyloidosis surgery
Directions to Hospitals Treating Cystic fibrosis
Risk calculators and risk factors for Renal amyloidosis surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview[edit | edit source]

In renal amyloidosis, surgery is usually reserved for patients developed with end stage renal disease. The patients with renal amyloidosis are good candidates for transplantation. In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.

Indications[edit | edit source]

In renal amyloidosis, surgery is usually reserved for patients developed with end stage renal disease.^[1]

Surgery[edit | edit source]

Renal transplantation[edit | edit source]

In renal amyloidosis, renal transplantation is an alternative approach to chronic dialysis.^[2]
The patients with renal amyloidosis are good candidates for transplantation.^[1]
In primary amyloidosis, renal transplantation is considered and it will improve long-term survival and quality of life.^[3]

References[edit | edit source]

↑ ^1.0 ^1.1 Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS (June 2012). "Outcome of patients with amyloidosis after renal transplantation: a single-center experience". Int J Artif Organs. 35 (6): 444–9. doi:10.5301/ijao.5000091. PMID 22562370.
↑ Heering P, Hetzel R, Grabensee B, Opelz G (June 1998). "Renal transplantation in secondary systemic amyloidosis". Clin Transplant. 12 (3): 159–64. PMID 9642504.
↑ Mahmood S, Palladini G, Sanchorawala V, Wechalekar A (February 2014). "Update on treatment of light chain amyloidosis". Haematologica. 99 (2): 209–21. doi:10.3324/haematol.2013.087619. PMC 3912950. PMID 24497558.

Template:WH Template:WS

[pmid225623702-1] 1.0 ^1.1 Gursu M, Yelken B, Caliskan Y, Kazancioglu R, Yazici H, Kilicaslan I, Turkmen A, Sever MS (June 2012). "Outcome of patients with amyloidosis after renal transplantation: a single-center experience". Int J Artif Organs. 35 (6): 444–9. doi:10.5301/ijao.5000091. PMID 22562370.

[pmid9642504-2] Heering P, Hetzel R, Grabensee B, Opelz G (June 1998). "Renal transplantation in secondary systemic amyloidosis". Clin Transplant. 12 (3): 159–64. PMID 9642504.

[pmid24497558-3] Mahmood S, Palladini G, Sanchorawala V, Wechalekar A (February 2014). "Update on treatment of light chain amyloidosis". Haematologica. 99 (2): 209–21. doi:10.3324/haematol.2013.087619. PMC 3912950. PMID 24497558.

[1]

[2]

[3]